• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

active pharmaceutical ingredients

Headshot of new AbbVie COO Robert Michael
Pharma

AbbVie plots $10B US outlay as pharma tariff threat looms

With the threat of drug tariffs sparking an investment rush in the U.S., AbbVie is laying plans to spend billions in the country over the next decade.
Fraiser Kansteiner Apr 25, 2025 11:52am
generic drugs pills tablets drugs

US generic drugs could get battered by tariffs, USP chief warns

Apr 23, 2025 4:12pm
President Donald Trump outlines new tariffs during an executive order signing event at the White House

Trump's 'Liberation Day' tariffs seem to spare drugs—for now

Apr 2, 2025 7:32pm
FDA

India's Aspen Biopharma Labs hit with FDA warning letter

Mar 26, 2025 1:09pm
Photo of a VikingNordic-era ship in the water while the sun sets behind it

Viking taps CordenPharma in $150M obesity drug production deal

Mar 11, 2025 10:25am
inspection investigation FDA FDA inspection

FDA hits Piramal with 6-observation Form 483 at India API plant

Feb 26, 2025 10:22am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings